Neonatal Abstinence Syndrome Incidence and Health Care Costs in the United States, 2016

Andrea E Strahan; Gery P Guy Jr; Michele Bohm; Meghan Frey; Jean Y Ko

doi:10.1001/jamapediatrics.2019.4791

Neonatal Abstinence Syndrome Incidence and Health Care Costs in the United States, 2016

JAMA Pediatr. 2020 Feb 1;174(2):200-202. doi: 10.1001/jamapediatrics.2019.4791.

Authors

Andrea E Strahan¹, Gery P Guy Jr¹, Michele Bohm¹, Meghan Frey², Jean Y Ko^{3

4}

Affiliations

¹ National Center for Injury Prevention and Control, Division of Overdose Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
² National Center on Birth Defects and Developmental Disabilities, Division of Congenital and Developmental Disorders, Centers for Disease Control and Prevention, Atlanta, Georgia.
³ National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
⁴ United States Public Health Service, Commissioned Corps, Rockville, Maryland.

Abstract

This cross-sectional study examines the national incidence rate of neonatal abstinence syndrome using data from the 2016 Healthcare Cost and Utilization Project Kids’ Inpatient Database.

Publication types

Letter

MeSH terms

Female
Health Care Costs*
Humans
Incidence
Infant, Newborn
Male
Neonatal Abstinence Syndrome / economics*
Neonatal Abstinence Syndrome / epidemiology*
United States / epidemiology